| CAT No: | CL-ESD-01 |
| CAS No: | 1446502-11-9 |
| Mol.F: | C19H17F6N7O |
| Mol.Wt.: | 473.4 |
| Chemical Name: | 2-Methyl-1-((4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)amino)propan-2-ol |
| Inventory Status: | Custom synthesis |
This impurity is related to Enasidenib is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Enasidenib is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:2-Methyl-1-((4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)amino)propan-2-olCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Enasidenib Molecular Formula: C19H17F6N7O
Molecular Weight: 473.4
Storage: Store in a cool, dry place.
| Product Name: | Enasidenib |
| CAS No: | 1446502-11-9 |
| Mol.F.: | C19H17F6N7O |
| Mol.Wt.: | 473.4 |
Cat. No: CL-ESD-NO-01
CAS No: NA
Mol. F: C19H16F6N8O2
Mol. Wt: 502.37
Inv. Status: Custom Synthesis
Cat. No: CL-ESD-NO-02
CAS No: NA
Mol. F: C19H15F6N9O3
Mol. Wt: 531.4
Inv. Status: Custom Synthesis
Cat. No: CL-ESD-NO-03
CAS No: NA
Mol. F: C19H16F6N8O2
Mol. Wt: 502.4
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: